Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Malignant Melanoma

  Free Subscription


05.02.2024

1 Am J Dermatopathol
1 Am J Ophthalmol
1 Ann Surg Oncol
1 Anticancer Res
2 Br J Dermatol
2 Cancer Lett
1 Clin Exp Metastasis
3 Eur J Dermatol
1 Int J Cancer
1 J Am Acad Dermatol
1 J Clin Invest
1 J Clin Oncol
2 J Invest Dermatol
1 Nat Rev Cancer
1 Oncogene


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Dermatopathol

  1. DONATI M, Grossmann P, Mansour B, Kazakov DV, et al
    Melanocytic Neoplasm With KIT and APC Mutations: A New Subtype of Melanocytoma?
    Am J Dermatopathol. 2023 Nov 14. doi: 10.1097/DAD.0000000000002556.
    PubMed         Abstract available


    Am J Ophthalmol

  2. HUANG JJ, Saleem A, Liao EX, Larocque M, et al
    Incidence of Strabismus Post Plaque Brachytherapy in Patients with Uveal Melanoma.
    Am J Ophthalmol. 2024 Jan 31:S0002-9394(24)00035.
    PubMed         Abstract available


    Ann Surg Oncol

  3. DEDEILIA A, Lwin T, Li S, Tarantino G, et al
    ASO Visual Abstract: Factors Affecting Recurrence and Survival in High-Risk Stage II Melanoma.
    Ann Surg Oncol. 2024 Feb 1. doi: 10.1245/s10434-023-14869.
    PubMed        


    Anticancer Res

  4. POPP K, Popp R, Bansal S, Sharan S, et al
    Disparities in Time-to-treatment for Patients With Melanoma.
    Anticancer Res. 2024;44:631-637.
    PubMed         Abstract available


    Br J Dermatol

  5. MUKHTAR AB, Morgan HJ, Gibbs A, Davies GE, et al
    Targeting CD20-expressing malignant melanoma cells augments BRAF inhibitor killing.
    Br J Dermatol. 2024 Jan 30:ljad502. doi: 10.1093.
    PubMed         Abstract available

  6. BERGAMASCHI D
    Improving cancer stem cells killing in malignant melanoma.
    Br J Dermatol. 2024 Jan 29:ljae035. doi: 10.1093.
    PubMed        


    Cancer Lett

  7. MIRZAEI H, Salehi H, Oskuee RK, Mohammadpour A, et al
    Retraction notice to "The therapeutic potential of human adipose-derived mesenchymal stem cells producing CXCL10 in a mouse melanoma lung metastasis model" [Cancer Lett. 419 (2018) 30-39].
    Cancer Lett. 2024 Feb 2:216670. doi: 10.1016/j.canlet.2024.216670.
    PubMed         Abstract available

  8. ZHANG J, Joshua AM, Yue L, O'Meara CH, et al
    Targeted therapy, immunotherapy, and small molecules and peptidomimetics as emerging immunoregulatory agents for melanoma.
    Cancer Lett. 2024 Jan 26:216633. doi: 10.1016/j.canlet.2024.216633.
    PubMed         Abstract available


    Clin Exp Metastasis

  9. SHARON CE, Karakousis GC
    Neoadjuvant therapy for resectable melanoma.
    Clin Exp Metastasis. 2024 Jan 28. doi: 10.1007/s10585-023-10263.
    PubMed         Abstract available


    Eur J Dermatol

  10. FUKUCHI K, Shimauchi T, Fujiyama T, Ito T, et al
    A case of bullous pemphigoid in a malignant melanoma patient following an increased Th2/Th1 ratio in peripheral blood cells after nivolumab treatment.
    Eur J Dermatol. 2023;33:550-551.
    PubMed        

  11. KIM PJ, Lansang RP, Ko E, Abu-Hilal M, et al
    Incidence of melanoma and non-melanoma skin cancer in patients with celiac disease: a systematic review and meta-analysis.
    Eur J Dermatol. 2023;33:506-513.
    PubMed         Abstract available

  12. VAN DIEREN L, Amar JZ, Geurs N, Quisenaerts T, et al
    Unveiling the power of convolutional neural networks in melanoma diagnosis.
    Eur J Dermatol. 2023;33:495-505.
    PubMed         Abstract available


    Int J Cancer

  13. VAN DUIN IAJ, Verheijden RJ, van Diest PJ, Blokx WAM, et al
    A prediction model for response to immune checkpoint inhibition in advanced melanoma.
    Int J Cancer. 2024 Jan 31. doi: 10.1002/ijc.34853.
    PubMed         Abstract available


    J Am Acad Dermatol

  14. KOOPER-JOHNSON S, Kasthuri V, Homer A, Nguyen BM, et al
    Higher Risk of Melanoma-related Deaths for Patients Residing in Rural Counties: A Surveillance, Epidemiology, and End Results Program Study.
    J Am Acad Dermatol. 2024 Jan 31:S0190-9622(24)00167.
    PubMed        


    J Clin Invest

  15. WU M, Hanly A, Gibson F, Fisher R, et al
    The CoREST repressor complex mediates phenotype switching and therapy resistance in melanoma.
    J Clin Invest. 2024 Feb 1:e171063. doi: 10.1172/JCI171063.
    PubMed         Abstract available


    J Clin Oncol


  16. Erratum: Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling.
    J Clin Oncol. 2024 Feb 1:JCO2400017. doi: 10.1200/JCO.24.00017.
    PubMed        


    J Invest Dermatol

  17. COLLENNE J, Monnier J, Iguernaissi R, Nawaf M, et al
    Fusion between an algorithm based on the characterization of melanocytic lesions asymmetry with an ensemble of CNN for melanoma detection.
    J Invest Dermatol. 2024 Jan 29:S0022-202X(24)00078.
    PubMed         Abstract available

  18. JEREMIAN R, Lytvyn Y, Fotovati R, Georgakopoulos JR, et al
    Distinct signatures of mitotic age acceleration in cutaneous melanoma and acquired melanocytic nevi.
    J Invest Dermatol. 2024 Jan 28:S0022-202X(24)00083.
    PubMed        


    Nat Rev Cancer

  19. RIAUD M, Maxwell J, Soria-Bretones I, Dankner M, et al
    The role of CRAF in cancer progression: from molecular mechanisms to precision therapies.
    Nat Rev Cancer. 2024;24:105-122.
    PubMed         Abstract available


    Oncogene

  20. XIAO Y, Zhou L, Andl T, Zhang Y, et al
    YAP1 controls the N-cadherin-mediated tumor-stroma interaction in melanoma progression.
    Oncogene. 2024 Feb 2. doi: 10.1038/s41388-024-02953.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.